Heartflow CFO Vikram Verghese sells $332,211 in shares By Investing.com

Vikram Verghese, Chief Financial Officer of Heartflow, Inc. (), sold 6,640 shares of the company’s common stock on September 8, 2026. The transaction totaled $332,211.

The shares were sold at prices ranging from $50.00 to $50.12 per share, with the reported price of $50.0319 reflecting the weighted average sale price. This sale was executed pursuant to a Rule 10b5-1 trading plan, which Mr. Verghese adopted on June 4, 2026. The timing of the sale comes after a remarkable 105% surge in the stock over the past six months, though shares have since pulled back to $45.49. Following this transaction, Mr. Verghese beneficially owns 214,503 shares of Heartflow common stock. For investors analyzing this insider activity, InvestingPro reveals the stock is currently overvalued according to its Fair Value analysis, and offers 8 additional ProTips to help assess the company’s investment potential. The platform’s comprehensive Pro Research Report provides clear, actionable intelligence on HTFL and 1,400+ other US equities.

In other recent news, HeartFlow Inc. reported its second-quarter 2026 financial results, showing significant improvements. The company posted adjusted earnings of negative $0.07 per share, beating Wall Street’s expectations of a negative $0.19 per share. Revenue for the quarter increased by 48% from the previous year, reaching $64.1 million, surpassing both Stifel’s projection of $56.7 million and consensus estimates of $56.6 million. This growth was attributed to strong demand in HeartFlow’s coronary artery disease diagnostics and its plaque and FFRCT businesses. Following these results, Stifel raised its price target for HeartFlow shares to $45.00 from $40.00, maintaining a Buy rating. These developments reflect the company’s ability to outperform market expectations and the positive outlook from analysts like Stifel.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.